Delivery Order SPE2DB24D2101-SPE2DB24FKGTX
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $8,078.21 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ramipril 10 mg capsules. The firm-fixed-price delivery order, valued at $4,289.63, has an ultimate completion date of January 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10mg capsules of the medication Ramipril. The $6,992.95 Firm Fixed Price contract has a completion date of September 25, 2024. AmerisourceBergen is delivering these medications to support military treatment facilities and other federal healthcare providers through this delivery order. No set-aside was used for this award....
This federal contract award, valued at $2,879.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This delivery order is for 4,563,273,583 units of the medication Ramipril 10 mg capsules, which are used to treat...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,727.69, is for the delivery of Ramipril 10 mg capsules. This is a Firm Fixed Price Delivery Order contract with a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The contract is a Delivery Order with a Firm Fixed Price and a ceiling value of $1,007.38. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ramipril 10 mg capsules. The contract, which has a ceiling value of $2,650.03, is a firm fixed-price delivery order with an ultimate completion date of August 26, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of 500 capsules of the prescription drug Ramipril 10 mg, valued at $1,949.35. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award, with a ceiling value of $1,604.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,086,379 capsules of the pharmaceutical drug Ramipril 2.5 mg. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...